Advisors Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.4M	Sell	177,703 -1,464	-0.8%	-$34.9K	0.07%	364
2025 Q4	$4.18M	Sell	179,167 -13,481	-7%	-$300K	0.07%	369
2025 Q3	$3.8M	Buy	192,648 +1,132	+0.6%	+$23.3K	0.06%	403
2025 Q2	$4.16M	Buy	191,516 +12,650	+7%	+$299K	0.07%	357
2025 Q1	$4.34M	Buy	178,866 +12,819	+8%	+$289K	0.08%	321
2024 Q4	$3.47M	Sell	166,047 -11,286	-6%	-$242K	0.06%	411
2024 Q3	$3.53M	Buy	177,333 +11,484	+7%	+$213K	0.06%	397
2024 Q2	$2.57M	Sell	165,849 -59,226	-26%	-$922K	0.05%	471
2024 Q1	$3.59M	Buy	225,075 +24,575	+12%	+$370K	0.07%	354
2023 Q4	$3.37M	Sell	200,500 -118,480	-37%	-$1.62M	0.07%	357
2023 Q3	$3.73M	Sell	318,980 -3,374	-1%	-$45.1K	0.08%	316
2023 Q2	$4.33M	Buy	322,354 +3,606	+1%	+$51.9K	0.09%	284
2023 Q1	$5.28M	Buy	318,748 +905	+0.3%	+$14.9K	0.11%	229
2022 Q4	$5.91M	Buy	317,843 +66,650	+27%	+$1.03M	0.12%	187
2022 Q3	$3.22M	Buy	251,193 +2,671	+1%	+$31.7K	0.07%	334
2022 Q2	$1.74M	Buy	248,522 +113,743	+84%	+$834K	0.03%	561
2022 Q1	$1.12M	Buy	134,779 +90,820	+207%	+$642K	0.02%	771
2021 Q4	$298K	Buy	+43,959	New	+$289K	﹤0.01%	1136